Skip to main content

Table 2 Perioperative medications in groups B and C

From: Better clinical outcome of total knee arthroplasty for rheumatoid arthritis with perioperative glucocorticoids and disease-modifying anti-rheumatic drugs after an average of 11.4-year follow-up

 

No. of cases

Median dosage

Median treatment duration

Group B

 LEF

5

15 mg daily

8 years

 MTX

9

12.5 mg weekly

10 years

 SASP

1

2000 mg daily

5 years

 TGP

1

1200 mg daily

0.5 years

 TG

7

40 mg daily

14 years

 ETN

2

25 mg biweekly

0.5 years

Group C

 IGU

2

50 mg daily

1 years

 MTX

18

12.5 mg weekly

12 years

 PA

1

1000 mg daily

6 years

 SASP

1

2000 mg daily

4 years

 TG

13

60 mg daily

8 years

 ETN

3

25 mg biweekly

0.5 years

 PRDL

4

7.5 mg daily

11.5 years

 PRED

16

10 mg daily

12 years

 MPS

1

8 mg bi-daily

21 years

  1. LEF leflunomide, MTX methotrexate, TGP total glucosides of paeony, TG tripterygium glycosides, SASP salicylazosulfapyridine, ETN etanercept, IGU iguratimod, PA penicillamine, PRDL prednisolone, PRED prednisone, MPS methylprednisolone
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X